We are live on ! Find out more
PALI icon

Palisade Bio

8 hedge funds and large institutions have $56.2M invested in Palisade Bio in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding

Funds holding: 78 (+1)

0% more ownership

Funds ownership: 0%0% (+0%)

2% less capital invested

Capital invested by funds: $57.1M → $56.2M (-$871K)

49% less call options, than puts

Call options by funds: $351K | Put options by funds: $691K

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
1
Reduced
Closed
Calls
$351K
Puts
$691K
Net Calls
-$340K
Net Calls Change
-$552K
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$275K
TC
27
TFS Capital
Pennsylvania
$270K
SIM
28
SSI Investment Management
California
$269K
TA
29
Teachers Advisors
New York
$262K
Wells Fargo
30
Wells Fargo
California
$229K
NFA
31
Nationwide Fund Advisors
Ohio
$146K
Commonwealth Equity Services
32
Commonwealth Equity Services
Massachusetts
$142K
WCM
33
Westend Capital Management
California
$136K
VOYA Investment Management
34
VOYA Investment Management
Georgia
$123K
ERIM
35
Eagle Ridge Investment Management
Connecticut
$122K
BA
36
BlackRock Advisors
Delaware
$121K
AIG
37
American International Group
New York
$118K
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$114K
GT
39
Greenleaf Trust
Michigan
$109K
VKH
40
Virtu KCG Holdings
New York
$95K
LTFS
41
Ladenburg Thalmann Financial Services
Florida
$84K
JPTCCM
42
J.P. Turner & Co Capital Management
Georgia
$82K
DC
43
Davenport & Co
Virginia
$78.3K
Citadel Advisors
44
Citadel Advisors
Florida
$71K
PNC Financial Services Group
45
PNC Financial Services Group
Pennsylvania
$67K
Creative Planning
46
Creative Planning
Kansas
$61K
GC
47
Guggenheim Capital
Illinois
$60K
ECM
48
EagleClaw Capital Management
Massachusetts
$58K
CFA
49
CT Financial Advisors
Pennsylvania
$55.2K
NES
50
New England Securities
New York
$54K

PALI Hedge Fund Activity: Q4 2014 in Review

8 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2014, worth a combined $56.2M — down 1.5% from $57.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PALI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $3.29M. The largest seller was Metropolitan Life Insurance Company (MetLife), cutting an estimated $183K.

  • 8 institutional investors held Palisade Bio (PALI) as of Q4 2014, up from 7 in Q3 2014.
  • Funds reported $56.2M of Palisade Bio stock for Q4 2014, down 1.5% quarter-over-quarter.
  • 1 fund opened new Palisade Bio positions in Q4 2014 and 0 closed out, a net change of +1 holder.
  • The largest Palisade Bio buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $3.29M added.
  • The largest Palisade Bio seller in Q4 2014 was Metropolitan Life Insurance Company (MetLife), an estimated $183K sold.

Based on aggregated 13F filings for Q4 2014.